Medlab Clinical Ltd. (MDLB)

Medlab Clinical was planning to go public, but the IPO was withdrawn on Jan 30, 2024.

IPO Price

$4.45

Shares Offered

1,797,752

Deal Size

$8.00M

Medlab Clinical Financials Overview

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Jun '22 Jun 30, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	1.54	1.54	0.73
Revenue Growth	-	109.68%	-
Gross Profit	1.2	1.2	0.72
Operating Income	-12.98	-12.98	-13.23
Net Income	-7.16	-7.16	-12.32

Fiscal Year	Current	FY 2022	FY 2021
Period Ending	Jun '22 Jun 30, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	5.19	5.19	13.43
Total Debt	1.12	1.12	1.7
Net Cash (Debt)	4.07	4.07	11.74
Net Cash Growth	-	-65.35%	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Jun '22 Jun 30, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	-9.41	-9.41	-10.35
Capital Expenditures	-0.03	-0.03	-0.08
Free Cash Flow	-9.44	-9.44	-10.43
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Jun '22 Jun 30, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Margin	78.11%	78.11%	97.76%
Operating Margin	-845.13%	-845.13%	-1804.94%
Pretax Margin	-466.19%	-466.19%	-1681.90%
Profit Margin	-466.19%	-466.19%	-1681.90%
FCF Margin	-614.57%	-614.57%	-1423.78%